Zhang Jin, Halm Susan T, Halm Dan R
Department of Neuroscience, Cell Biology and Physiology, Wright State University Boonshoft School of Medicine, Dayton, Ohio 45435, USA.
Am J Physiol Gastrointest Liver Physiol. 2009 Aug;297(2):G278-91. doi: 10.1152/ajpgi.00077.2009. Epub 2009 Jun 4.
Adrenergic activation of electrogenic K+ secretion in isolated mucosa from guinea pig distal colon was desensitized by peptide-YY (PYY). Addition of PYY or neuropeptide-Y (NPY) to the bathing solution of mucosae in Ussing chambers suppressed the short-circuit current (Isc) corresponding to electrogenic Cl- secretion, whether stimulated by epinephrine (epi), prostaglandin-E2 (PGE2), or carbachol (CCh). Neither peptide markedly inhibited the large transient component of synergistic secretion (PGE2 + CCh). Sustained Cl- secretory Isc was inhibited approximately 65% by PYY or NPY, with IC50s of 4.1 +/- 0.9 nM and 9.4 +/- 3.8 nM, respectively. This inhibition was eliminated by BIIE0246, an antagonist of the Y2-neuropeptide receptor (Y2-NpR), but not by Y1-NpR antagonist BVD10. Adrenergic sensitivity for activation of K+ secretion in the presence of Y2-NpR blockade by BIIE0246 was (EC50s) 2.9 +/- 1.2 nM for epi and 13.3 +/- 1.0 nM for norepinephrine, approximately fourfold greater than in the presence of PYY. Expression of mRNA for both Y1-NpR and Y2-NpR was indicated by RT-PCR of RNA from colonic mucosa, and protein expression was indicated by immunoblot. Immunoreactivity (ir) for Y1-NpR and Y2-NpR was distinct in basolateral membranes of columnar epithelial cells in the crypts of Lieberkühn as well as intercrypt surface epithelium. Adrenergic nerves in proximity with crypts were detected by ir for dopamine-beta-hydroxylase, and a portion of these nerves also contained NPY(ir). BIIE0246 addition increased secretagog-activated Isc, consistent with in vitro release of either PYY or NPY. Thus PYY and NPY were able to suppress Cl- secretory capacity and desensitize the adrenergic K+ secretory response, providing a direct inhibitory counterbalance against secretory activation.
肽YY(PYY)使豚鼠远端结肠分离黏膜中电生性钾分泌的肾上腺素能激活脱敏。在尤斯灌流小室中,向黏膜浴液中添加PYY或神经肽Y(NPY)可抑制对应于电生性氯分泌的短路电流(Isc),无论其是由肾上腺素(epi)、前列腺素 - E2(PGE2)还是卡巴胆碱(CCh)刺激引起的。两种肽均未显著抑制协同分泌(PGE2 + CCh)的大的瞬时成分。PYY或NPY使持续的氯分泌Isc抑制约65%,其半数抑制浓度(IC50)分别为4.1±0.9 nM和9.4±3.8 nM。Y2 - 神经肽受体(Y2 - NpR)拮抗剂BIIE0246可消除这种抑制作用,但Y1 - NpR拮抗剂BVD10则不能。在BIIE0246阻断Y2 - NpR的情况下,肾上腺素激活钾分泌的敏感性(半数有效浓度,EC50)对于epi为2.9±1.2 nM,对于去甲肾上腺素为13.3±1.0 nM,约为存在PYY时的四倍。通过对结肠黏膜RNA进行逆转录 - 聚合酶链反应(RT - PCR)表明Y1 - NpR和Y2 - NpR的mRNA均有表达,通过免疫印迹表明蛋白表达。在利伯kühn隐窝的柱状上皮细胞基底外侧膜以及隐窝间表面上皮中,Y1 - NpR和Y2 - NpR的免疫反应性(ir)是不同的。通过多巴胺 - β - 羟化酶的ir检测到靠近隐窝的肾上腺素能神经,并且这些神经中的一部分也含有NPY(ir)。添加BIIE0246可增加促分泌剂激活的Isc,这与PYY或NPY的体外释放一致。因此,PYY和NPY能够抑制氯分泌能力并使肾上腺素能钾分泌反应脱敏,对分泌激活提供直接的抑制性平衡。